Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihong Yang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hematology (Amsterdam, Netherlands)|November 17, 2023
Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantationQingqing Fan, Xiang Hui, Xiang Li, et al.
Peerj|October 16, 2023
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic studyJunfeng Zhu, Gaoqi Xu, Dihong Yang, et al.
Journal of Clinical Pharmacology|April 5, 2023
Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant TumorsGaoqi Xu, Dihong Yang, Qi Shu, et al.
Annals of Translational Medicine|March 14, 2022
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factorYinghui Tong, Dihong Yang, Xiufang Mi, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2024
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancerDihong Yang, Gaoqi Xu, Haiying Ding, et al.
Journal of Chemotherapy (Florence, Italy)|April 23, 2024
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with <i>Staphylococcus Aureus</i> by pharmacokinetic/pharmacodynamic analysisGaoqi Xu, Xin Liu, Jiaqi Wang, et al.
Cellular Signalling|June 5, 2025
Acetaldehyde dehydrogenase 1A1 upregulation drives dacomitinib-induced skin toxicity through mitochondrial dysfunction and keratinocyte apoptosisWanying Zhou, Xinyue Ma, Lili Tan, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2023
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancerGaoqi Xu, Dihong Yang, Chaoneng He, et al.
European Journal of Clinical Pharmacology|June 21, 2024
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancerGaoqi Xu, Dihong Yang, Haiying Ding, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hematology (Amsterdam, Netherlands)|November 17, 2023
Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantationQingqing Fan, Xiang Hui, Xiang Li, et al.
Peerj|October 16, 2023
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic studyJunfeng Zhu, Gaoqi Xu, Dihong Yang, et al.
Journal of Clinical Pharmacology|April 5, 2023
Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant TumorsGaoqi Xu, Dihong Yang, Qi Shu, et al.
Annals of Translational Medicine|March 14, 2022
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factorYinghui Tong, Dihong Yang, Xiufang Mi, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2024
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancerDihong Yang, Gaoqi Xu, Haiying Ding, et al.
Journal of Chemotherapy (Florence, Italy)|April 23, 2024
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with <i>Staphylococcus Aureus</i> by pharmacokinetic/pharmacodynamic analysisGaoqi Xu, Xin Liu, Jiaqi Wang, et al.
Cellular Signalling|June 5, 2025
Acetaldehyde dehydrogenase 1A1 upregulation drives dacomitinib-induced skin toxicity through mitochondrial dysfunction and keratinocyte apoptosisWanying Zhou, Xinyue Ma, Lili Tan, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2023
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancerGaoqi Xu, Dihong Yang, Chaoneng He, et al.
European Journal of Clinical Pharmacology|June 21, 2024
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancerGaoqi Xu, Dihong Yang, Haiying Ding, et al.
Pageof 1